Literature DB >> 1914458

Effects of various IUDs on the composition of cervical mucus.

B Jonsson1, B M Landgren, P Eneroth.   

Abstract

The influence of three different intrauterine devices on the composition of cervical mucus was studied. The amount of mucin, albumin and immunoglobulin G was estimated. After the insertion of an inert IUD, a decrease in mucin was observed. During copper-IUD use the content of mucin, albumin and IgG was increased in cervical mucus, while weight was not affected. In the levonorgestrel-IUD users, ovulation was inhibited in 2 out of 8 women. Mucus weight was increased. The amounts of mucin, albumin and IgG were not changed. In an in vitro experiment the effect of copper-IUDs on autooxidation of cholesterol was studied. There was an extensive conversion of cholesterol but addition of albumin quenched the oxidation of cholesterol. It is suggested that the increased secretion of albumin induced by copper-IUD users may offer protection against copper-induced cell damage.

Entities:  

Keywords:  Biology; Cervical Mucus; Cervix; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--pharmacodynamics; Endocrine System; Estradiol; Estrogens; Family Planning; Genitalia; Genitalia, Female; Hormones; Iud, Copper Releasing--pharmacodynamics; Iud, Hormone Releasing--pharmacodynamics; Iud, Unmedicated--pharmacodynamics; Iud--pharmacodynamics; Levonorgestrel; Physiology; Progestational Hormones; Progesterone; Research Methodology; Urogenital System; Uterus

Mesh:

Substances:

Year:  1991        PMID: 1914458     DOI: 10.1016/0010-7824(91)90135-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

Review 1.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

Review 2.  Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).

Authors:  Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2016-02-12       Impact factor: 8.661

3.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Comparing cervical mucus changes in response to an oral progestin or oestrogen withdrawal in ovarian-suppressed women: a clinical pilot.

Authors:  Leo Han; Emily Padua; Kyle D Hart; Alison Edelman; Jeffrey T Jensen
Journal:  Eur J Contracept Reprod Health Care       Date:  2019-05-08       Impact factor: 1.848

5.  Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle.

Authors:  Mahboobeh Safaeian; Roni T Falk; Ana Cecilia Rodriguez; Allan Hildesheim; Troy Kemp; Marcus Williams; Lidiana Morera; Manuel Barrantes; Rolando Herrero; Carolina Porras; Ligia Pinto
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

6.  Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.

Authors:  Chandra Kailasam; David Cahill
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.